Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Booster Doses of COVID-19 Vaccine in Immunocompromised Patients With a Cancer Diagnosis

NCT05016622 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT05016622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05016622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Booster Doses of COVID-19 Vaccine in Immunocompromised Patients With a Cancer Diagnosis
Lead sponsor
Montefiore Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
August 10, 2021
Completion date
May 21, 2023
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer